OUR PRODUCTS

Our approved products developed with TransCon® technology

Approved products

Ascendis Pharma medicines using TransCon technology are authorized for the indications and in the countries or regions shown below. Please note that in some countries, a medicine may be authorized for marketing but not yet commercially available.

Growth Hormone Deficiency

Compound

lonapegsomatropin*

Trade Name

SKYTROFA®
Developed as TransCon hGH

Authorized In

United States

European Union
& EEA**

Available In:

*lonapegsomatropin-tcgd in the United States
**EEA = European Economic Area

Hypoparathyroidism

Compound

palopegteriparatide

Trade Name

YORVIPATH®
Developed as TransCon PTH

Authorized In

United States

European Union,
EEA, & UK**

Available In:

**EEA = European Economic Area. UK = United Kingdom

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

CONFIRM DENY

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

CONFIRM DENY

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

GO CANEL

Are you a resident of the United States?

If so, please confirm below to proceed to our website for the United States. If not, you can stay here on our global site.

GO
(U.S. residents only) STAY
(Global)

Are you a resident of Austria?

If so, please confirm below to proceed to our website for Austria. If not, you can stay here on our global site.

GO
(Austria residents only) STAY
(Global)

Are you a resident of Germany?

If so, please confirm below to proceed to our website for Germany. If not, you can stay here on our global site.

GO
(German residents only) STAY
(Global)

Are you a resident of Spain?

If so, please confirm below to proceed to our website for Spain. if not, you can stay here on the our global site.

GO
(Spanish residents only) STAY
(Global)